REQUEST – FCF LIFE SCIENCES RESEARCH SERIES

FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.
The findings are regularly published in
NEWS & PRESS
Venture Capital Sentiment Tracker – April 2023
April 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend

Life Sciences Venture Capital Monitor – Europe 04/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 04/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences

FCF Biotech Venture Capital Monitor – USA 03/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 03/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
Venture Capital Sentiment Tracker – March 2023
March 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend

Life Sciences Venture Capital Monitor – Europe 03/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 03/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences